Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Payables (2020 - 2023)

Historic Payables for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to $250000.0.

  • Candel Therapeutics' Payables fell 7422.68% to $250000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $250000.0, marking a year-over-year decrease of 7422.68%. This contributed to the annual value of $380000.0 for FY2022, which is 7610.06% down from last year.
  • As of Q3 2023, Candel Therapeutics' Payables stood at $250000.0, which was down 7422.68% from $480000.0 recorded in Q2 2023.
  • Candel Therapeutics' Payables' 5-year high stood at $1.6 million during Q4 2021, with a 5-year trough of $250000.0 in Q3 2023.
  • For the 4-year period, Candel Therapeutics' Payables averaged around $894272.7, with its median value being $921000.0 (2020).
  • Within the past 5 years, the most significant YoY rise in Candel Therapeutics' Payables was 10869.57% (2022), while the steepest drop was 7610.06% (2022).
  • Quarter analysis of 4 years shows Candel Therapeutics' Payables stood at $921000.0 in 2020, then surged by 72.64% to $1.6 million in 2021, then crashed by 76.1% to $380000.0 in 2022, then tumbled by 34.21% to $250000.0 in 2023.
  • Its Payables was $250000.0 in Q3 2023, compared to $480000.0 in Q2 2023 and $592000.0 in Q1 2023.